Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record with results posted

A Phase 4, Randomized, Blinded, Active-Controlled Study of HTX-011 in Subjects Undergoing Different Surgical Procedures, Cohort 2: Abdominoplasty

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06109428
Title field or adapter rule
{'original_value': 'A Phase 4, Randomized, Blinded, Active-Controlled Study of HTX-011 in Subjects Undergoing Different Surgical Procedures, Cohort 2: Abdominoplasty', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At
2026-10-29T01:00:17.534842+00:00
Published At
2026-10-28T00:00:00+00:00
Record Updated At
2026-10-28
Results Posted At
2026-10-28
Source Retrieved At
2026-10-29T01:00:16.864611+00:00
Timestamp Basis
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Postoperative Pain", "Abdominoplasty Surgery", "Multimodal Analgesia"]
protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-10-28", "type": "ACTUAL"}
protocolSection.identificationModule.nctId
"NCT06109428"
protocolSection.identificationModule.officialTitle
"A Phase 4, Randomized, Blinded, Active-Controlled Study of HTX-011 in Subjects Undergoing Different Surgical Procedures, Cohort 2: Abdominoplasty"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct
{"date": "2026-10-28", "type": "ACTUAL"}

Study condition terms

  • Postoperative Pain (protocolSection.conditionsModule.conditions)
  • Abdominoplasty Surgery (protocolSection.conditionsModule.conditions)
  • Multimodal Analgesia (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

  • {'armGroupLabels': ['Bupivacaine HCl + MMA', 'HTX-011 + MMA'], 'description': 'acetaminophen 1 g every 8 hours (q8h) and ibuprofen 400 mg q8h, alternating the 2 medications so that an analgesic was taken approximately every 4 hours (q4h)', 'name': 'MMA regimen', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['HTX-011 + MMA'], 'description': 'ZYNRELEF kits include sterile, individually packaged components for administration, including vented vial spikes, Luer lock syringes, custom Luer lock applicators, and syringe tip caps.', 'name': 'ZYNRELEF kit components for administration', 'type': 'DEVICE'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['HTX-011 + MMA'], 'description': 'HTX-011 (bupivacaine/meloxicam) extended-release solution for instillation use, supplied in commercially available ZYNRELEF kits', 'name': 'HTX-011', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Bupivacaine HCl + MMA'], 'description': 'Bupivacaine HCl (without epinephrine) 0.25%', 'name': 'Bupivacaine Hydrochloride', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

  • MMA regimen (protocolSection.armsInterventionsModule.interventions[].name)
  • HTX-011 (protocolSection.armsInterventionsModule.interventions[].name)
  • Bupivacaine Hydrochloride (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.